Development of Allogeneic Stem Cell Transplantation & Modern T cell Therapies Webinar
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Sub type
Certificate awarded

About this item

Description: This session will give an historic overview about the development of allogeneic stem cell transplantation in context with the developments in the field of immunology, as both areas are closely linked. It will then highlight how the concept of T cell therapy was discovered and how more recent developments have emerged based on the observations from allogeneic stem cell transplantation.

Start date: Upon registration

Completion: Up to 52 weeks

Course/Activity Information

At the end of this webinar you will learn how:

  • Allogeneic stem cell transplantation was developed
  • The concept of T cell therapy evolved
  • This translates into recent T cell therapy approaches


Speaker: Dr. Armin Gerbitz, Cell Processing Lab (CPL), Princess Margaret Cancer Centre

Armin Gerbitz received his medical training at the University of Munich in Germany and became part of the Munich stem cell transplantation team in 1995. After his post doc at the Dana Farber Cancer Institute in Boston in1999, he continued his training at various places and eventually became attending physician at the Charite in Berlin. He continued as program director at the Charite Berlin until he moved to Canada in 2019. He currently is staff physician at the Hans Messner allogeneic stem cell transplantation Program and Medical Director of the Orsino Cell Processing Lab at Princess Margaret Cancer Centre. He is married and has two daughters who keep him honest.


Recorded: February 3, 2021


PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.

Shopping Cart
Total:  Close

Loading Shopping Cart Items...